Squamous cell carcinoma

Aug 09, 2018

BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China

Jun 06, 2018

Skin Cancer Diagnostics Market: In Depth Global Overview With Focus on Driving Factors, Restraining Factors, Competitive Landscape and Forecast 2013-2025

Apr 30, 2018

FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma

Apr 24, 2018

ASX/NASDAQ Announcement

Apr 03, 2018

EMA to Review Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma

Mar 05, 2018

Benitec Biopharma Launches its Phase 2 Oncology Study in Australia

Dec 19, 2017

CAP Launches Guideline to Ensure Accurate HPV Testing in Head and Neck Cancers

Dec 13, 2017

Regeneron and Sanofi Announce Positive Topline Pivotal Results for PD-1 Antibody Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma

Aug 29, 2017

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2017

Jun 21, 2017

Vigilant Biosciences Announces Further Clinical Data in Support of its OncAlert® Oral Cancer Product Line at IFOS ENT World Congress 2017 Symposium and at Annual MASCC Meeting

Jun 05, 2017

Boston Biomedical Presents Data for Investigational Stemness Inhibitor Amcasertib at ASCO 2017